← Eichor
Study identifier: NCT05968807 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients

Condition: Solid Organ Transplant  ·  Sponsor: The Hospital for Sick Children

PhaseNA
Planned participants55
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.

This description comes directly from the study's public registry record.

Talk to the study team

Samantha J. Anthony, PhD, MSW  ·  416-813-7654  ·  samantha.anthony@sickkids.ca

Sophie Bui, BHSc  ·  sophie.bui@sickkids.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital for Sick ChildrenToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05968807